Thyroid Pharmacology

Correct Answer

C — Methimazole

Rationale

Methimazole is a thionamide antithyroid drug that inhibits thyroid peroxidase, blocking both organification of iodide and coupling of iodotyrosines within the thyroid follicular lumen. Propranolol is a non-selective beta-adrenergic receptor antagonist used as an adjunct in hyperthyroidism. Levothyroxine is a synthetic thyroid hormone replacement. Dexamethasone is a glucocorticoid included in thyroid storm protocols — none of these are thionamide antithyroid agents.

Correct Answer

A — Lugol's iodine solution

Rationale

Lugol's iodine solution is an iodide preparation containing 5% iodine and 10% potassium iodide. It is used as an adjunct in hyperthyroidism to exploit the Wolff-Chaikoff effect and reduce thyroid gland vascularity before surgery or as part of thyroid storm management. Saturated solution of potassium iodide is the other major iodide preparation in this class. Cholestyramine is a bile acid sequestrant. Methimazole is a thionamide antithyroid drug. Propranolol is a beta-adrenergic receptor antagonist.

Correct Answer

D — Potassium perchlorate

Rationale

Potassium perchlorate is an iodide-depleting agent that competes with iodide at the sodium-iodide symporter, blocking further iodide uptake and depleting intrathyroidal iodine stores. It is added to high-dose methimazole in type 1 amiodarone-induced thyrotoxicosis, where high intrathyroidal iodine content attenuates thionamide efficacy. Methimazole is a thionamide antithyroid drug. Propranolol is a beta-adrenergic receptor antagonist. Cholestyramine is a bile acid sequestrant — none of these are iodide-depleting agents.

Correct Answer

B — Propranolol

Rationale

Propranolol is the preferred beta-blocker in thyroid storm because at high doses (80–160 mg per day) it inhibits type 1 deiodinase, reducing peripheral thyroxine-to-triiodothyronine conversion by approximately 10–20% in addition to its beta-adrenergic blockade. This dual action provides an advantage over cardioselective agents such as atenolol, metoprolol, and bisoprolol, which block only cardiac beta-1 receptors and do not inhibit deiodinase activity.

Correct Answer

A — Dexamethasone

Rationale

Dexamethasone is a potent glucocorticoid included in thyroid storm protocols at 2 mg intravenously every 6 hours. Hydrocortisone is an alternative glucocorticoid used in the same role at 100 mg intravenously every 8 hours — both are glucocorticoids and both are used in thyroid storm, but dexamethasone is the specific agent named in the storm protocol. Methimazole and propylthiouracil are thionamide antithyroid drugs, not glucocorticoids.

Correct Answer

C — Atenolol

Rationale

Atenolol is a cardioselective beta-1 adrenergic receptor antagonist, preferentially blocking cardiac beta-1 receptors while having less effect on bronchial beta-2 receptors. It is used as an alternative to propranolol in thyrotoxic patients with reactive airway disease. Propranolol is a non-selective beta-adrenergic antagonist blocking both beta-1 and beta-2 receptors. Labetalol blocks both alpha-1 and beta receptors. Clonidine is an alpha-2 adrenergic receptor agonist, not a beta-blocker.

Correct Answer

B — Cholestatic pattern with elevated alkaline phosphatase and bilirubin, generally mild and reversible

Rationale

Methimazole produces a cholestatic hepatotoxicity pattern — elevated alkaline phosphatase and bilirubin — that is generally mild and reversible on drug discontinuation. This contrasts with propylthiouracil, which causes idiosyncratic fulminant hepatic necrosis carrying a black box warning after cases of liver failure, liver transplantation, and death, predominantly in children. This divergence in hepatotoxicity severity is one of the primary reasons propylthiouracil is restricted to specific indications rather than used as first-line therapy. Methimazole does not cause steatohepatitis or markedly elevated transaminases.

Correct Answer

D — Long-term propylthiouracil induces antineutrophil cytoplasmic antibody formation in up to 4% of users, causing small vessel vasculitis

Rationale

Propylthiouracil is associated with antineutrophil cytoplasmic antibody-positive vasculitis in up to 4% of long-term users. The precise mechanism is not fully established but involves drug-induced autoimmunity with formation of antibodies against neutrophil cytoplasmic antigens, leading to small vessel vasculitis affecting the kidneys, lungs, and skin. This adverse effect is a major reason propylthiouracil is considered a poor choice for prolonged therapy and is reserved for specific short-term indications. Methimazole does not carry this vasculitis risk.

Correct Answer

A — Weeks 6–10, corresponding to the period of active organogenesis

Rationale

Methimazole embryopathy — which includes aplasia cutis, choanal atresia, and esophageal atresia — occurs during organogenesis at approximately weeks 6–10 of gestation, when structural development of multiple organ systems is underway and the embryo is most susceptible to teratogenic insults. Propylthiouracil does not carry the same teratogenic risk during this window and is therefore preferred for first-trimester management of Graves disease. After organogenesis is complete at approximately 16 weeks, therapy is switched back to methimazole to avoid propylthiouracil's hepatotoxicity risk during the remainder of pregnancy.

Correct Answer

C — Iodide given before thyroid peroxidase is blocked provides substrate for new hormone synthesis, paradoxically increasing thyroid hormone output

Rationale

The Wolff-Chaikoff effect — whereby high iodide transiently inhibits thyroid peroxidase — requires time to establish and depends on iodide concentrations already above a threshold. If iodide is administered first, it enters thyroid follicular cells via the sodium-iodide symporter and becomes available as substrate for thyroid peroxidase-mediated organification before inhibition is achieved, potentially driving a surge in thyroid hormone synthesis. Once thionamide has been given for at least one hour and thyroid peroxidase inhibition is established, iodide can be added safely. In thyroid storm, propylthiouracil must precede iodide by at least one hour for this reason. Iodide does not compete for thionamide binding sites or block thionamide entry into follicular cells.

Correct Answer

B — Cholestyramine binds thyroid hormone in the intestinal lumen, interrupting enterohepatic recirculation and reducing the circulating hormone pool

Rationale

Thyroid hormone undergoes enterohepatic recirculation — hepatic conjugation with glucuronide or sulfate, biliary secretion into the intestinal lumen, and reabsorption. Cholestyramine, a positively charged bile acid sequestrant resin, binds thyroid hormone (along with bile acids) in the intestinal lumen and prevents its reabsorption, directing it toward fecal elimination. By interrupting this recirculation loop, cholestyramine reduces the total circulating hormone pool more rapidly than hormone clearance alone. This mechanism is additive to thionamide-mediated synthesis blockade in severe or refractory thyrotoxicosis.

Correct Answer

D — Glucocorticoids inhibit thyroid hormone secretion, inhibit type 1 deiodinase to reduce triiodothyronine generation, and cover the risk of relative adrenal insufficiency

Rationale

Glucocorticoids serve three simultaneous roles in thyroid storm management: they inhibit thyroid hormone secretion from follicular cells; they inhibit type 1 deiodinase, reducing peripheral thyroxine-to-triiodothyronine conversion and lowering active hormone levels; and they provide coverage for relative adrenal insufficiency, which can occur when extreme physiological stress exhausts cortisol reserve in a patient with unrecognized or marginal adrenal function. This triple action makes glucocorticoids an indispensable component of the storm protocol. They do not block thyroid-stimulating hormone receptors, increase thyroxine-binding globulin, or inhibit thyroid peroxidase.

Correct Answer

A — Small goiter, mild biochemical hyperthyroidism, and thyroid-stimulating hormone receptor antibodies normalizing during treatment

Rationale

Favorable remission predictors after thionamide therapy in Graves disease are small goiter size, mild biochemical hyperthyroidism at presentation, and normalization of thyroid-stimulating hormone receptor antibodies during treatment — suggesting that the autoimmune drive is waning. Conversely, large goiter, high initial antibody titers, and persistent antibodies at the end of a treatment course predict 60–70% relapse within one year of stopping. When relapse occurs after a first course, a second course rarely achieves remission and definitive therapy should be recommended. Stable antibodies throughout treatment, as in option D, are not associated with favorable remission.

Correct Answer

C — Methimazole impairs radioactive iodine uptake by the thyroid, reducing the radiation dose delivered to thyroid tissue

Rationale

Methimazole inhibits thyroid peroxidase-mediated organification of iodide within the follicular lumen. When iodine-131 is taken up by the sodium-iodide symporter but cannot be organified and incorporated into thyroglobulin, it is not retained within the gland and washes out — reducing the effective radiation dose delivered to thyroid tissue and impairing ablation efficacy. Stopping methimazole 5–7 days before administration allows the drug to clear and organification to resume, ensuring that radioactive iodine is trapped and retained for its intended ablative effect. Methimazole does not chemically inactivate iodine-131 or increase thyroid vascularity.

Correct Answer

D — Agranulocytosis is a thionamide class effect, so rechallenge with propylthiouracil carries the same risk and is contraindicated

Rationale

Thionamide-induced agranulocytosis is an idiosyncratic immune-mediated class effect — the immune mechanism is directed against a property shared by both methimazole and propylthiouracil, not one unique to either drug. A patient who develops agranulocytosis on methimazole cannot safely be switched to propylthiouracil, because the same reaction is expected. This class-effect contraindication forecloses the entire thionamide drug class and makes definitive therapy with radioactive iodine or thyroidectomy necessary. The agranulocytosis mechanism has nothing to do with thyroid peroxidase activity or bone marrow suppression from granulocyte colony-stimulating factor.

Correct Answer

B — Salicylates displace thyroid hormones from binding proteins, acutely raising free hormone concentrations; acetaminophen is used because it does not affect protein binding

Rationale

Aspirin and other salicylates displace thyroxine and triiodothyronine from their plasma binding proteins — thyroxine-binding globulin, transthyretin, and albumin — by competing for binding sites. This displacement acutely raises free hormone concentrations at a time when end-organ stress from thyroid storm is already maximal, potentially worsening the crisis. Acetaminophen does not compete for thyroid hormone binding sites and is the preferred agent for fever and pain management throughout thyroid storm. Salicylates do not inhibit thyroid peroxidase, induce thionamide metabolism, or activate thyroid-stimulating hormone receptors.

Correct Answer

A — Radioactive iodine-induced thyroid destruction releases thyroid antigens that amplify the autoimmune response targeting orbital fibroblasts; glucocorticoid prophylaxis reduces this risk

Rationale

Radioactive iodine destroys thyroid follicular cells over 6–12 weeks, releasing thyroid antigens into the circulation. In Graves disease, where the autoimmune process already targets thyroid-stimulating hormone receptor-expressing tissues including orbital fibroblasts, this antigen release can amplify the immune response and worsen ophthalmopathy in 15–20% of patients, particularly smokers. Oral glucocorticoid prophylaxis — typically prednisone starting on the day of treatment and tapered over three months — reduces this worsening to rates comparable with thionamide therapy alone. Prompt levothyroxine replacement after ablation is standard practice to minimize thyroid-stimulating hormone elevation, which also contributes to orbital inflammation, but it does not replace glucocorticoid prophylaxis in the peri-treatment period.

Correct Answer

C — Methimazole exerted a direct teratogenic effect on developing embryonic tissues during organogenesis at weeks 6–10, producing structural malformations independent of thyroid hormone

Rationale

Methimazole embryopathy — which includes aplasia cutis, choanal atresia, esophageal atresia, and facial dysmorphic features — results from a direct teratogenic effect of the drug on embryonic tissue during organogenesis at weeks 6–10, not from suppression of fetal thyroid hormone synthesis. The fetal thyroid is not yet functional during organogenesis, and propylthiouracil shares the same thyroid peroxidase inhibition mechanism without producing the same structural defects, confirming a drug-specific teratogenic property. This is why propylthiouracil is preferred in the first trimester despite its hepatotoxicity risk: it carries a lower teratogenic burden during the organogenesis window.